💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Meridian Bioscience Inc. (VIVO)
« Back to company indexVIVO Chatter Timeline
Stock Ticker for VIVO
Most Active Tweeters for VIVO
| User | Tweets |
|---|---|
| @Tickeron | 6 |
| @newsfilterio | 3 |
| @StockNewsBot2 | 2 |
| @FlashAlert_me | 2 |
| @Briefingcom | 2 |
Recent Tweets for VIVO
 |
@newsfilterio Meridian Bioscience Announces Retirement of CFO Bryan Baldasare $VIVO https://t.co/UILBmTPDoW December 3rd 2021, 2:12am |
 |
@BestoTrading Awaiting Buy signal on $VIVO with UltraAlgo. https://t.co/bnlTNhVo4i December 2nd 2021, 6:12pm |
 |
@Briefingcom $VIVO: Meridian Bioscience announces the retirement of CFO Bryan Baldasare https://t.co/SHKAyY5xUy December 2nd 2021, 3:12pm |
 |
@mehabecapital $VIVO @ 19.56 (-1.76%) : Meridian Bioscience announces retirement of CFO https://t.co/ndaImEz7w7 December 2nd 2021, 1:12pm |
 |
@MaisaCorp $VIVO announced today that Bryan Baldasare, Executive Vice President, Chief Financial Officer, and Secretary, will… https://t.co/pdPbjSgEcU December 2nd 2021, 1:12pm |
 |
@StockNewsBot2 $VIVO Meridian Bioscience Announces Retirement of CFO Bryan Baldasare https://t.co/9Dmh49Wlxx December 2nd 2021, 1:12pm |
 |
@quantisnow $VIVO ? Meridian Bioscience Announces Retirement of CFO Bryan Baldasare https://t.co/RzTMLMBq9w 45 seconds delayed. December 2nd 2021, 1:12pm |
 |
@stock_titan $VIVO Meridian Bioscience Announces Retirement of CFO Bryan Baldasare https://t.co/kBPTnX00Wa December 2nd 2021, 1:12pm |
 |
@Tickeron $VIVO's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/ghGFoHYbVN December 2nd 2021, 9:12am |
|
@Tickeron Do you agree with the A.I. prediction? $VIVO The volume increased for one day, resulting in a record-breaking daily… https://t.co/v8WlkM56td December 2nd 2021, 7:12am |
|
@Tickeron How does this affect your portfolio? $VIVO MACD Histogram turned negative on November 30, 2021. #MeridianBioscience… https://t.co/VUvEfSuqKi December 2nd 2021, 5:12am |
 |
@OptionHunt Ticker $VIVO Unusual Volume Detected: 198.12% over average December 1st 2021, 4:12pm |
 |
@LeviTrade2 $VIVO Awaiting Buy Signal. Stock Trading Ideas by https://t.co/TpxWPHxKVP https://t.co/X3csDqUtUD December 1st 2021, 3:12pm |
|
@Tickeron $VIVO in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/r1EIrxHX6w November 30th 2021, 9:11pm |
|
@BestoTrading Awaiting Buy signal on $VIVO with UltraAlgo. https://t.co/T4RtNdw0k3 November 30th 2021, 6:11pm |
 |
@42Stocks 2021-NOV-26 3:05pm $VIVO #Meridian_Bio Meridian Bioscience up 3.46% = $29.5 million gain. https://t.co/Qm2Z41qf2G… https://t.co/iDbtcOl4zE November 26th 2021, 8:11pm |
|
@Briefingcom $VIVO: Meridian Bioscience announces that David Phillips, Chairman of the Board of Directors, will retire from the.… https://t.co/qnuzhvCnwJ November 24th 2021, 4:11pm |
 |
@theflynews Meridian Bioscience Chairman David Phillips retiring $VIVO https://t.co/3WcngR1FRu November 24th 2021, 3:11pm |
 |
@MarketCurrents $VIVO - Meridian Bioscience Chairman David Phillips retiring https://t.co/u6KlGkkki3 November 24th 2021, 2:11pm |
 |
@FlashAlert_me $VIVO [15s. delayed]: Issued Press Release on November 24, 09:05:00: Meridian Bioscience Announces Retirement of Ch… https://t.co/3Q5GbJjwII November 24th 2021, 2:11pm |
 |
@63_hyacinth Meridian Bioscience Chairman David Phillips retiring $VIVO November 24th 2021, 2:11pm |
|
@StockNewsBot2 $VIVO Meridian Bioscience Announces Retirement of Chairman David Phillips https://t.co/gjMFNkradK November 24th 2021, 2:11pm |
 |
@ZoZoStockwatch RT @TheTradeXchange: $VIVO: Meridian Bioscience Announces Retirement of Chairman David Phillips November 24th 2021, 2:11pm |
|
@newsfilterio Meridian Bioscience Announces Retirement of Chairman David Phillips $VIVO https://t.co/mccT6O9G3E November 24th 2021, 2:11pm |
|
@stock_titan $VIVO Meridian Bioscience Announces Retirement of Chairman David Phillips https://t.co/ul0s8RCMh1 November 24th 2021, 2:11pm |
 |
@TheTradeXchange $VIVO: Meridian Bioscience Announces Retirement of Chairman David Phillips November 24th 2021, 2:11pm |
|
@newsfilterio Form 10-K (annual report [section 13 and 15(d), not s-k item 405]) filed with the SEC $VIVO https://t.co/lA4NgB52Y1 November 24th 2021, 10:11am |
 |
@ShogunTrade $VIVO Awaiting Short Signal. Stock Trading Ideas by https://t.co/6vnULU2sSf https://t.co/cZBsgE89X1 November 23rd 2021, 3:11pm |
|
@FlashAlert_me $VIVO [15s. delayed] filed form 10-K on November 23, 08:46:09 https://t.co/N1k0Z3kGLA November 23rd 2021, 1:11pm |
 |
@TradeWithAlerts A nice print for $VIVO at 5:23pm -- SIDE: Between Click https://t.co/gkhoURBPN5 for more. Runners ?:… https://t.co/iS7mFNqEN2 November 22nd 2021, 10:11pm |
 |
@A1Syad $VIVO Awaiting short signal. Stock Trading Ideas by https://t.co/1MjnDHV7ua https://t.co/OQ41AYabV5 November 22nd 2021, 5:11pm |
 |
@Uncletrade1 $VIVO Waiting for Short signal on VIVO https://t.co/9524Yw1oQD November 22nd 2021, 4:11pm |
 |
@pennies_pretty $VIVO Broke out of a bullish pennant on the weekly https://t.co/zcQGt9reV2 November 22nd 2021, 1:11pm |
 |
@richmakestrades Watchlist: $VIVO recent earnings growth , 11/17 news about ground-breaking clinical lab process, back above 200 da… https://t.co/v0Ieiiidz1 November 21st 2021, 7:11pm |
|
@Tickeron $VIVO's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/ApKSZ9Md9j November 21st 2021, 4:11pm |
|
@Tickeron A.I.dvisor made a bullish call on $VIVO, netting in a 9.05% gain over 1 week #MeridianBioscience #stockmarket… https://t.co/ZaWuGkezLV November 21st 2021, 1:11pm |
 |
@10xJames $VIVO - setup for Monday buy: $21.72 stop: 20.74 target: 24.66 - bouncing off 10EMA - breaking out of a base - goo… https://t.co/yzrHAn8Dnd November 20th 2021, 8:11pm |
|
@Uncletrade1 $VIVO Waiting for Short signal on VIVO https://t.co/rVNgOuh5jr November 20th 2021, 6:11pm |
 |
@AndyandAndy_ @WeedStreet420 $vivo has a gmp facility, they can by the whole LP for 30m usd November 19th 2021, 9:11pm |
|
@42Stocks 2021-NOV-19 4:00pm $VIVO #Meridian_Bio Meridian Bioscience up 6.23% = $54.7 million gain. https://t.co/ErthwZzWng… https://t.co/k0nv5UGBC1 November 19th 2021, 9:11pm |
 |
@NoGuessTrading Our $VIVO trade closed after 166 days and 7 rolls! It fell 29% since entry, but WE STILL MADE +11.3% annualized ret… https://t.co/3nxGVakT1i November 19th 2021, 5:11pm |
 |
@MarcJacksonLA $VIVO Meridian Bioscience Participates in Piper Sandler 33rd Annual Virtual Healthcare Conference https://t.co/w5GC9Vwhhf November 18th 2021, 10:11pm |
|
@OptionHunt Ticker $VIVO Unusual Volume Detected: 83.65% over average November 18th 2021, 7:11pm |
|
@FlashAlert_me $VIVO [15s. delayed]: Issued Press Release on November 18, 14:05:00: Meridian Bioscience Participates in Piper Sand… https://t.co/ZmSdz6nflZ November 18th 2021, 7:11pm |
|
@newsfilterio Meridian Bioscience Participates in Piper Sandler 33rd Annual Virtual Healthcare Conference $VIVO https://t.co/fdxxyzdOM4 November 18th 2021, 7:11pm |
|
@ShogunTrade $VIVO Awaiting Short Signal. Algo Trading by https://t.co/6vnULU2sSf https://t.co/zD47vD6gH7 November 18th 2021, 1:11pm |
|
@BestoTrading Awaiting Short signal on $VIVO with UltraAlgo. https://t.co/a2On4thh5J November 17th 2021, 6:11pm |
|
@TheTradeXchange $VIVO: Meridian Launches Two New Air-Dryable™ Mixes for Isothermal Amplification, Powering Shortest Time-to-results in Point-of-care Testing November 17th 2021, 3:11pm |
|
@StockNewsBot2 $VIVO Meridian Launches Two New Air-Dryable™ Mixes for Isothermal Amplification, Powering Shortest Time-to-results… https://t.co/rIIfIxh55d November 17th 2021, 3:11pm |
|
@stock_titan $VIVO Meridian Launches Two New Air-Dryable™ Mixes for Isothermal Amplification, Powering Shortest Time-to-results… https://t.co/uQNGfoYWWQ November 17th 2021, 3:11pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?